IONS

Ionis Pharmaceuticals Inc (IONS)

US
$ 33.533.94%

Price Chart

Key Statistics

Market Cap
$ 5.49B
P/E Ratio
0.00
Revenue (TTM)
$ 717.25M
Volume
1.37M
52W High
$ 52.34
52W Low
$ 23.95
Dividend Yield
0.00%
Beta
0.15

Technicals

50-Day MA
30.9518
200-Day MA
36.3792
52 Week High
52.34
52 Week Low
23.95

About IONS

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Employees
1069
Headquarters
Carlsbad, CA
CEO
Dr. Brett P. Monia Ph.D.

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score
36.64
Percentile: 62.18
Environmental Risk Score
5.18
Percentile: 9
Social Risk Score
26.17
Percentile: 9
Governance Risk Score
13.29
Percentile: 9

Controversy Level

ESG data provided by Sustainalytics, Inc.

IONS
Category Average
N/ANone Controversy Level
NoneSevere

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg